title: Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?
authors.forename: M
authors.initials: M
authors.lastname: Horwitz
authors.forename: A
authors.initials: A
authors.lastname: Stewart
authors.forename: S L
authors.initials: SL
authors.lastname: Greenspan
mesh_terms: D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D019379:Teriparatide / Q000627:therapeutic use
chemical_list: D010281:Parathyroid Hormone; D019379:Teriparatide; D019386:Alendronate